| SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia A Moutal, LF Martin, L Boinon, K Gomez, D Ran, Y Zhou, HJ Stratton, ... Pain 162 (1), 243-252, 2021 | 165 | 2021 |
| Hierarchical CRMP2 posttranslational modifications control NaV1. 7 function ET Dustrude, A Moutal, X Yang, Y Wang, M Khanna, R Khanna Proceedings of the National Academy of Sciences 113 (52), E8443-E8452, 2016 | 126 | 2016 |
| Long-lasting antinociceptive effects of green light in acute and chronic pain in rats MM Ibrahim, A Patwardhan, KB Gilbraith, A Moutal, X Yang, LA Chew, ... Pain 158 (2), 347-360, 2017 | 117 | 2017 |
| CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide A Moutal, X Yang, W Li, KB Gilbraith, S Luo, S Cai, L François-Moutal, ... Pain 158 (12), 2301-2319, 2017 | 87 | 2017 |
| A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2. 2 trafficking and reverses inflammatory and postoperative pain behaviors L François-Moutal, Y Wang, A Moutal, KE Cottier, OK Melemedjian, ... Pain 156 (7), 1247-1264, 2015 | 84 | 2015 |
| Dysregulation of CRMP2 post-translational modifications drive its pathological functions A Moutal, KA White, A Chefdeville, RN Laufmann, PF Vitiello, D Feinstein, ... Molecular neurobiology 56, 6736-6755, 2019 | 79 | 2019 |
| A light-gated potassium channel for sustained neuronal inhibition L Alberio, A Locarno, A Saponaro, E Romano, V Bercier, S Albadri, ... Nature methods 15 (11), 969-976, 2018 | 70 | 2018 |
| Blocking CRMP2 SUMOylation reverses neuropathic pain A Moutal, ET Dustrude, TM Largent-Milnes, TW Vanderah, M Khanna, ... Molecular psychiatry 23 (11), 2119-2121, 2018 | 68 | 2018 |
| (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation … A Moutal, LA Chew, X Yang, Y Wang, SK Yeon, E Telemi, S Meroueh, ... Pain 157 (7), 1448-1463, 2016 | 66 | 2016 |
| Inhibition of the Ubc9 E2 SUMO-conjugating enzyme–CRMP2 interaction decreases NaV1. 7 currents and reverses experimental neuropathic pain L François-Moutal, ET Dustrude, Y Wang, T Brustovetsky, A Dorame, W Ju, ... Pain 159 (10), 2115-2127, 2018 | 65 | 2018 |
| The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females Y Chen, A Moutal, E Navratilova, C Kopruszinski, X Yue, M Ikegami, ... Science translational medicine 12 (529), eaay7550, 2020 | 64 | 2020 |
| Targeting T-type/CaV3. 2 channels for chronic pain S Cai, K Gomez, A Moutal, R Khanna Translational Research 234, 20-30, 2021 | 62 | 2021 |
| Dissecting the role of the CRMP2–neurofibromin complex on pain behaviors A Moutal, Y Wang, X Yang, Y Ji, S Luo, A Dorame, SS Bellampalli, ... Pain 158 (11), 2203-2221, 2017 | 62 | 2017 |
| (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5 A Moutal, L François-Moutal, S Perez-Miller, K Cottier, LA Chew, SK Yeon, ... Molecular neurobiology 53, 1959-1976, 2016 | 62 | 2016 |
| Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury–associated peripheral sensory neuropathy via block of N-and T … SS Bellampalli, Y Ji, A Moutal, S Cai, EMK Wijeratne, MA Gandini, J Yu, ... Pain 160 (1), 117-135, 2019 | 61 | 2019 |
| Synaptic zinc inhibition of NMDA receptors depends on the association of GluN2A with the zinc transporter ZnT1 RF Krall, A Moutal, MB Phillips, H Asraf, JW Johnson, R Khanna, ... Science advances 6 (27), eabb1515, 2020 | 56 | 2020 |
| A porcine model of neurofibromatosis type 1 that mimics the human disease KA White, VJ Swier, JT Cain, JL Kohlmeyer, DK Meyerholz, MR Tanas, ... JCI insight 3 (12), 2018 | 55 | 2018 |
| Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain A Moutal, S Luo, TM Largent-Milnes, TW Vanderah, R Khanna Neurobiology of Pain 5, 100022, 2019 | 50 | 2019 |
| Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides A Moutal, L François-Moutal, JM Brittain, M Khanna, R Khanna Frontiers in cellular neuroscience 8, 471, 2015 | 47 | 2015 |
| Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry S Perez-Miller, M Patek, A Moutal, P Duran, CR Cabel, CA Thorne, ... ACS chemical neuroscience 12 (8), 1299-1312, 2021 | 46 | 2021 |
Rajesh KhannaProfessor of Pharmacology and TherapeuticsZweryfikowany adres z ufl.edu